- Home
- WVE vs BJRI Comparison
WVE vs BJRI Comparison
Compare WVE & BJRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WVE
- BJRI
- Stock Information
- Founded
- WVE 2012
- BJRI 1978
- Country
- WVE Singapore
- BJRI United States
- Employees
- WVE N/A
- BJRI N/A
- Industry
- WVE Biotechnology: Pharmaceutical Preparations
- BJRI Restaurants
- Sector
- WVE Health Care
- BJRI Consumer Discretionary
- Exchange
- WVE Nasdaq
- BJRI Nasdaq
- Market Cap
- WVE 939.3M
- BJRI 856.1M
- IPO Year
- WVE 2015
- BJRI 1996
- Fundamental
- Price
- WVE $6.35
- BJRI $43.58
- Analyst Decision
- WVE Strong Buy
- BJRI Hold
- Analyst Count
- WVE 11
- BJRI 5
- Target Price
- WVE $20.91
- BJRI $38.25
- AVG Volume (30 Days)
- WVE 1.7M
- BJRI 601.8K
- Earning Date
- WVE 05-08-2025
- BJRI 05-01-2025
- Dividend Yield
- WVE N/A
- BJRI N/A
- EPS Growth
- WVE N/A
- BJRI N/A
- EPS
- WVE N/A
- BJRI 0.95
- Revenue
- WVE $104,939,000.00
- BJRI $1,367,941,000.00
- Revenue This Year
- WVE N/A
- BJRI $5.50
- Revenue Next Year
- WVE N/A
- BJRI $3.28
- P/E Ratio
- WVE N/A
- BJRI $45.79
- Revenue Growth
- WVE N/A
- BJRI 2.91
- 52 Week Low
- WVE $4.25
- BJRI $27.61
- 52 Week High
- WVE $16.74
- BJRI $41.72
- Technical
- Relative Strength Index (RSI)
- WVE 40.37
- BJRI 78.08
- Support Level
- WVE $5.62
- BJRI $37.05
- Resistance Level
- WVE $7.07
- BJRI $39.35
- Average True Range (ATR)
- WVE 0.60
- BJRI 1.45
- MACD
- WVE 0.01
- BJRI 0.96
- Stochastic Oscillator
- WVE 26.35
- BJRI 95.39
About WVE Wave Life Sciences Ltd.
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
About BJRI BJ's Restaurants Inc.
BJ's Restaurants Inc is involved in the business of owning and operating restaurants. The company operates in a single operating segment that is full-service company-owned restaurants. It has geographic presence only in the United States of America.